พบ "Public health policy"ทั้งหมด 1,233 ผลลัพธ์
เรียงลำดับตาม
เรียงลำดับตาม
วันที่อัปเดตล่าสุด

Pattern of OPD utilisation during the COVID-19 pandemic under the Universal Coverage Scheme in Thailand: what can 850 million records tell us?

Out-patient department (OPD) is a crucial component of the healthcare systems in low- and middle-income countries including Thailand. A considerable impact of coronavirus disease 2019 (COVID-19) pandemic and its control measures, especially the lockdown, on utilisation of OPD services was expected.

What are the impacts of increasing cost-effectiveness Threshold? a protocol on an empirical study based on economic evaluations conducted in Thailand

conomic evaluations have been widely used to inform and guide policy-making process in healthcare resources allocation as a part of an evidence package. An intervention is considered cost-effective if an ICER is less than a cost-effectiveness threshold (CET), where a CET represents the acceptable pr

‘Science is only half of it’: Expert perspectives on operationalising infectious disease control cooperation in the ASEAN region

Governmental awareness of the potential spread of infectious disease, exemplified by the current Covid-19 pandemic, ideally results in collective action, as countries coordinate a response that benefits all, contributing expertise, resources, knowledge and experience to achieve a common public good.

Telemedicine utilization patterns and implications amidst covid-19 outbreaks in Thailand under public universal coverage scheme

Abstract During COVID-19 pandemic, telemedicine was a strategy to facilitate healthcare service delivery minimizing the risk of direct exposure among people. In Thailand, the National Health Security Office has included telemedicine services under the Universal Coverage Scheme to support social d

Expanding access to high-cost medicines under the Universal Health Coverage scheme in Thailand: review of current practices and recommendations

There is a growing demand for public health insurance programmes to reimburse high-cost medicines, including those that do not represent good value-for-money. This demand is likely to inhibit financial sustainability, given the growth of new technologies and public demands for expanded access to car

A Retrospective Secondary Data Analysis of Telemedicine Service Utilization (2020-2023) Among Patients Covered By The Universal Coverage Scheme in Thailand

Abstract Objective: The National Health Security Office in Thailand introduced a telemedicine program called “Telehealth/Telemedicine” in December 2020, which aimed to reimburse telemedicine services for patients with stable chronic diseases under the Universal Coverage Scheme (UCS). The current

Early health technology assessment of tongue swab for non-sputum based pulmonary tuberculosis diagnosis in Thailand

Background Sputum-based diagnostic methods for pulmonary tuberculosis (PTB) are challenging for patients who cannot produce sputum. Non-sputum-based approaches, such as tongue swab (TS), can address this gap. This study conducts an early Health Technology Assessment (HTA) of TS for PTB diagnosi

Understanding healthcare demand and supply through causal loop diagrams and system archetypes: policy implications for kidney replacement therapy in Thailand

Abstract Background Systems thinking approaches can determine system interdependencies to guide effective policymaking but have been underutilised in health policymaking, particularly for policies related to access and delivery of health services. In Thailand, a policy changing access to dialy

Assessing the Impact of Telemedicine Interventions on Health Care Costs and Utilization: A Scoping Review

Abstract Background: The impact of telemedicine on health care costs and utilization has not been comprehensively assessed across diverse health care settings. This scoping review aimed to explore these impacts, focusing on the variations in intervention types. Methods: A literature search follo

Assessing the Value for Money of Enzyme Replacement Therapy in Gaucher Disease Types 1 and 3b: Can Expanded Coverage Be Justified?

Abstract Background and Objectives The Health Intervention and Technology Assessment Program was commissioned to conduct a cost–utility and budget impact analysis of enzyme replacement therapy (ERT) for Gaucher disease types 1 and 3b. The findings from this assessment are to support the decision-m
10 / หน้า